Effectiveness and safety of ustekinumab in patients with Crohn's disease: a real-world experience

被引:0
|
作者
Mohammad, D. [1 ,2 ]
Alshahrani, A. [1 ,2 ,3 ]
Bao, Y. [1 ,2 ]
Alramdan, R. [1 ,2 ]
Rajani, A. [1 ,2 ]
Chauhan, U. [1 ,2 ]
Salena, B. [1 ,2 ]
Tse, F. [1 ,2 ]
Greenwald, E. [1 ,2 ]
Albashir, S. [1 ,2 ]
Halder, S. [1 ,2 ]
Armstrong, D. [1 ,2 ]
Marshall, J. [1 ,2 ]
Narula, N. [1 ,2 ]
机构
[1] McMaster Univ, Med Ctr, Gastroenterol, Hamilton, ON, Canada
[2] Farncombe Family Digest Hlth Dis Res Inst, Hamilton, ON, Canada
[3] Najran Univ, Gastroenterol, Najran, Saudi Arabia
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P484
引用
收藏
页码:S426 / S426
页数:1
相关论文
共 50 条
  • [41] Real-world clinical effectiveness and safety of vedolizumab and ustekinumab in biologic-naive patients with Crohn's disease: Results from the EVOLVE Expansion study
    Ferrante, M.
    Christensen, B.
    Bressler, B.
    Brett, N.
    Bassel, M.
    Kamble, P.
    Adsul, S.
    Gianchetti, L.
    Scharl, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2023, 17 : 768 - 769
  • [42] Real-world clinical effectiveness and safety of vedolizumab and ustekinumab in biologic-naive patients with Crohn's disease: Results from the EVOLVE Expansion study
    Ferrante, M.
    Christensen, B.
    Bressler, B.
    Brett, N.
    Bassel, M.
    Kamble, P.
    Adsul, S.
    Gianchetti, L.
    Scharl, M.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 116 - 117
  • [43] Real-World Evidence of the Effectiveness and Safety of Ustekinumab for the Treatment of Crohn's Disease: Systematic Review and Meta-Analysis of Observational Studies
    Rubin de Celix, Cristina
    Chaparro, Maria
    Gisbert, Javier P.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (14)
  • [44] An Australian Real-World Study of Treatment Persistence of Ustekinumab in Crohn's Disease
    Chien, Tzu Hsiang
    Puig, Andrea
    Khuong, Thang
    Kouhkamari, Mahsa H.
    Che, Samuel
    Huang, Tom Hsun-Wei
    [J]. BIOLOGICS-TARGETS & THERAPY, 2021, 15 : 237 - 245
  • [45] Ustekinumab treatment persistence in Crohn's disease: An Australian real-world study
    Chien, T. H.
    Huang, Th-W
    Puig, A.
    Khuong, T.
    Kouhkamari, M. H.
    Che, S.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 91 - 91
  • [46] Real-world short-term effectiveness of ustekinumab in 305 patients with Crohn's disease: results from the ENEIDA registry
    Iborra, M.
    Beltran, B.
    Fernandez-Clotet, A.
    Gutierrez, A.
    Antolin, B.
    Huguet, J. M.
    De Francisco, R.
    Merino, O.
    Carpio, D.
    Garcia-Lopez, S.
    Mesonero, F.
    Navarro, P.
    Ferreiro-Iglesias, R.
    Carbajo, A. Y.
    Rivero, M.
    Gisbert, J. P.
    Pinero-Perez, M. C.
    Monfort, D.
    Bujanda, L.
    Garcia-Sepulcre, M. F.
    Martin-Cardona, A.
    Canete, F.
    Taxonera, C.
    Domenech, E.
    Nos, P.
    Sierra-Ausin, M.
    Ferrer-Rosique, J. A.
    Martin-Arranz, M. D.
    Gonzalez-Munoza, C.
    Mancenido, N.
    Rodriguez-Lago, I.
    Benitez, J. M.
    Fores-Bosch, A.
    Navarro-Llavat, M.
    Calafat, M.
    Madrigal-Dominguez, R. E.
    Ramos, L.
    Arroyo, M.
    Busquets, D.
    Lorente, R.
    Sainz-Arnau, E.
    Hernandez-Camba, A.
    Morales-Alvarado, V. J.
    Paredes, J. M.
    Van Domselaar, M.
    Hervas, D.
    Canada-Martinez, A.
    Castro-Poceiro, J.
    Cameo-Lorenzo, J.
    Fernandez-Salazar, L.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (03) : 278 - 288
  • [47] Real World Ustekinumab Use in Pediatric Patients With Crohn's Disease
    Ritter, Timothy E.
    Sarles, Harry E.
    Whitney, Annette E.
    Kim-Romo, Dawn N.
    Van Anglen, Lucinda J.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S1056 - S1056
  • [48] Efficacy and safety of upadacitinib during induction in Crohn's disease: Real-world experience
    Jairath, R.
    Zoughlami, A.
    Pilote, N.
    Afif, W.
    Bitton, A.
    Wild, G.
    Narula, N.
    Lakatos, P. L.
    Bessissow, T.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1337 - I1337
  • [49] Real-world clinical effectiveness and safety of vedolizumab and ustekinumab in biologic-naive patients with Crohn's disease by disease location: Results from the EVOLVE Expansion study
    Scharl, M.
    Christensen, B.
    Bressler, B.
    Brett, N. R.
    Gianchetti, L.
    Kamble, P.
    Adsul, S.
    Farhat, Z.
    Ferrante, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1194 - I1195
  • [50] Real-world long-term effectiveness of ustekinumab in Crohn's disease: results from the ENEIDA registry
    Iborra, Marisa
    Beltran, Belen
    Fernandez-Clotet, Agnes
    Iglesias-Flores, Eva
    Navarro, Pablo
    Rivero, Montserrat
    Gutierrez, Ana
    Sierra-Ausin, Monica
    Mesonero, Francisco
    Ferreiro-Iglesias, Rocio
    Hinojosa, Joaquin
    Calvet, Xavier
    Sicilia, Beatriz
    Gonzalez-Munoza, Carlos
    Antolin, Beatriz
    Gonzalez-Vivo, Maria
    Carbajo, Ana Y.
    Garcia-Lopez, Santiago
    Martin-Cardona, Albert
    Suris, Gerard
    Dolores Martin-Arranz, Maria
    de Francisco, Ruth
    Canete, Fiorella
    Domenech, Eugeni
    Nos, Pilar
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (06) : 1017 - 1030